Ruzzo, A., Graziano, F., Galli, F., Galli, F., Rulli, E., Lonardi, S., . . . Magnani, M. (2019). Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Sci Rep.
Dyfyniad Arddull ChicagoRuzzo, Annamaria, et al. "Sex-Related Differences in Impact On Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy." Sci Rep 2019.
Dyfyniad MLARuzzo, Annamaria, et al. "Sex-Related Differences in Impact On Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy." Sci Rep 2019.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.